SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the United States Patent Office allowed its patent ...
SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of the Kurin ® blood culture collection sets, announced today that the Food and Drug Administration has issued a 510(k) clearance ...
Steripath ® Initial Specimen Diversion Device ®, a clinically proven solution, enables hospitals to meet the new goal of 1% blood culture contamination as published in CLSI's M47 Principles and ...
All 12 studies showed a reduced blood culture contamination rate after introducing Kurin Lock. Most of the studies were based in the US but there were 3 quality improvement studies based in NHS ...
The success of blood cultures is dependent on the collection of uncontaminated specimens, culture of a large volume of blood, and inoculation of multiple media types to maximize the recovery of most ...
SEATTLE, Dec. 7, 2021 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination for ...
The FDA sent a letter to healthcare providers July 10 regarding the shortage, and the CDC released updated conservation strategies in a July 22 statement. The FDA estimates the shortage will continue ...
A blood culture is a routine laboratory test in which blood – or another sterile body fluid – is taken from a patient and inoculated into bottles containing specialized media to determine whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results